Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora MedFort is a medical technology company focused on developing and commercializing advanced wound care solutions. The company's primary focus is on utilizing cold atmospheric plasma technology to treat chronic and non-healing wounds, such as diabetic foot ulcers and venous leg ulcers. Their flagship products aim to accelerate the healing process by reducing bacterial load and stimulating tissue regeneration. Aurora MedFort operates primarily in the European and Asian markets, providing clinicians with innovative tools to manage complex wound cases. The company positions itself at the intersection of biotechnology and medical devices, leveraging physical plasma science for therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora MedFort.